1. Home/
  2. Compounds/
  3. navitoclax:birinapant (1:1 mol/mol)

navitoclax:birinapant (1:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2navitoclax:birinapant (1:1 mol/mol)
PharmacoGx navitoclax:birinapant (1:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to navitoclax:birinapant (1:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA MRPL24 CTRPv2 pan-cancer AAC -0.22 1e-09
mRNA NBPF15 CTRPv2 pan-cancer AAC -0.2 6e-08
mRNA DAP3 CTRPv2 pan-cancer AAC -0.2 8e-08
mRNA C2orf47 CTRPv2 pan-cancer AAC -0.19 4e-07
mRNA MTX1 CTRPv2 pan-cancer AAC -0.19 3e-07
mRNA THEM4 CTRPv2 pan-cancer AAC -0.18 4e-06
mRNA NIT1 CTRPv2 pan-cancer AAC -0.18 2e-07
mRNA MRPL9 CTRPv2 pan-cancer AAC -0.18 6e-07
mRNA HAX1 CTRPv2 pan-cancer AAC -0.18 1e-06
mRNA FAM72D CTRPv2 pan-cancer AAC -0.18 3e-05
Download CSV